# OnCo record cullgen (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/cullgen/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "cullgen" ;
  schema:name "Cullgen"@en ;
  schema:description "Cullgen designs drugs that tag disease-causing proteins for destruction by the cell's own recycling system, and links such drugs to antibodies. In May 2026 it became part of Gyre Therapeutics, a US and China company focused on fibrosis."@en ;
  schema:url <https://onco.cc/companies/cullgen/>, <https://www.cullgen.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.cullgen.com/>, <https://www.sec.gov/Archives/edgar/data/1124105/000114036126018716/ef20072211_ex99-1.htm>, <https://www.cullgen.com/s/Cullgen-Gyreagreementpressrelease-4c4h.pdf> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/>, <https://onco.cc/technologies/degrader-antibody-conjugate/> .